Application
17343016 · 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
Filed 2021-06-09 · Abandoned The official file ↗ · Art unit 1626 · Examiner Karen Cheng Typical · CPC A61P 35/00 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
26.7 mo
to disposition 35.0 mo
Statutes raised
112 DP
1 actions read